News
Larger absolute rivaroxaban benefit in diabetes: COMPASS
- Author:
- Sue Hughes
The new vascular low dose of rivaroxaban has had a slow start, but these results may stimulate use in patients...
News
UK TAVI: Similar outcomes to surgery in real world
- Author:
- Sue Hughes
The trial confirms that the results of previous trials in low- to intermediate-risk patients can also be replicated in real-world clinical...
News
TAILOR-PCI: Clopidogrel genotyping trial narrowly misses endpoint
- Author:
- Sue Hughes
The trial missed its ambitious primary endpoint of a 50% reduction in cardiovascular events, but experts felt that it still should change practice...
News
Dramatic rise in hypertension-related deaths in the United States
- Author:
- Sue Hughes
The ‘alarming’ increase in hypertension-related deaths between 2007 and 2017, was particularly prominent in the rural South.
News
First clinical evidence of neuroprotection in acute stroke?
- Author:
- Sue Hughes
LOS ANGELES – A potential neuroprotectant was beneficial for patients with ischemic stroke undergoing thrombectomy in the ESCAPE-NA1 trial.
News
TNK dose in large-vessel stroke: 0.25 mg/kg is sufficient
- Author:
- Sue Hughes
New data from a second EXTEND-IA TNK (tenecteplase) trial clarify the optimum dose of the bolus thrombolytic for use in ischemic stroke.
News
New Vascepa indication opens up treatment to millions; “Most significant event since statins”
- Author:
- Sue Hughes
The high-dose fish oil product is being touted as the most significant event in cardiovascular prevention since...